Clinical development and Perspectives of CImAvax EgF, Cuban Vaccine for Non-small-cell Lung Cancer therapy
por hamit | Jun 24, 2017 | editorales-medicas |
Entradas recientes
- CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer
- «Health Tourism in Cuba»
- Immunotherapy and lung cancer: current developments and novel targeted therapies
- «Cuba Found A Cancer Vaccine!»
- CiMAvax-eGF: A New Therapeutic vaccine for Advanced Non-Small Cell Lung Cancer Patients
Comentarios recientes